Peer Review History
| Original SubmissionFebruary 28, 2025 |
|---|
|
Dear Dr. Shirzad, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Morteza Arab-Zozani, Ph. D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We are unable to open your Supporting Information file Archive.zip. Please kindly revise as necessary and re-upload. 3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear Respectable Authors After gathering the opinions of our reviewers, we have reached a decision regarding your article. Our decision is: Minor Revision Please send the response to reviewers file as soon as possible and also highlighted the changes in the main text. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Partly Reviewer #4: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: Dear Authors, Thank you for the opportunity to review your protocol for the scoping review titled "Using Safe and Ethical Technology to Prevent and Respond to Sexual and Interpersonal Violence: Identifying Evidence, Best Practices, and Pathways Forward." I commend your work on addressing such a vital and timely topic. Your protocol is well-structured, transparent, and largely adheres to PRISMA-P standards for scoping reviews. The inclusion of supplementary materials, such as the detailed search strategy and extraction form, is a significant strength and demonstrates commitment to methodological rigor. Below, I provide detailed feedback by section, with recommendations to further enhance the clarity, completeness, and transparency of your protocol. 1. Summary (Abstract) • The abstract provides a concise overview of the rationale, objectives, and methods. • To further improve clarity, consider specifying the types of studies included (e.g., qualitative, quantitative, mixed-methods) directly in the summary. This will help readers quickly understand the scope and methodological breadth of your review. 2. Background and Study Objectives • The background is comprehensive and well-referenced, clearly establishing the need for this review. • To strengthen this section, explicitly reference any previous systematic or scoping reviews on similar topics and clarify how your review specifically addresses the existing gaps identified in previous literature. For example, detail the unique aspects of safety and ethical considerations that have not been systematically synthesized to date (aspects like data protection regulations, user consent, or risk management strategies could add depth). • Clearly delineating primary and secondary objectives would enhance the reader’s understanding of your review’s focus areas and priorities. 3. Methods • The methods section is generally robust, with clear descriptions of the search strategy, screening, and data extraction processes. • Specify exclusion criteria more explicitly (e.g., non-English studies, non-youth populations, non-technology interventions). Additionally, provide a more detailed justification for the selected timeframe (2008 to present), explaining its relevance to the evolution of technology in this field. • Clarify how grey literature or unpublished studies will be handled, as this can impact the comprehensiveness of your review. 4. Supplementary Materials • The inclusion of a detailed search strategy and extraction form is a notable strength, supporting reproducibility and transparency. 5. Limitations • The protocol acknowledges the limitation of including only English-language studies, which may introduce language bias. This is appropriate, but you may also wish to discuss any other potential limitations, such as the challenges in synthesizing a highly heterogeneous evidence base. In summary, your protocol is methodologically sound and addresses a critical area of public health. Addressing the points above will further enhance its clarity, transparency, and alignment with best practices for scoping reviews. I look forward to seeing the results of your important work. Reviewer #2: Thank you for this important forward thinking innovation to the field! -Consider revising the title & short title to include 'youth' or 'young people' as an important descriptor. -Review grammar in abstract Obj sentence 1. -Consider revising the terms used. Interpersonal violence is not typically considered a sub-category of GBV as stated in line 55. Rather, interpersonal violence includes a wider range of behaviors including community (gang, etc) violence. I think the term implies a bigger scope than is envisioned here. You might mean intimate partner violence? See https://www.ncbi.nlm.nih.gov/books/NBK525208/. Consider aligning with a recent terminology pub: https://ecpat.org/wp-content/uploads/2025/04/Second-Edition-Terminology-Guidelines-final.pdf -Please add definitions of terms such as 'online grooming', 'revenge pornography', and 'sextortion' -Please include the full list of search terms -Did you consider including online research on experiences of SV/GBV? It could be an important addition for the field. -Please add a citation for the sentence: "a pivotal age range when SIV rates are at their highest before decreasing." -Consider expanding the resources for grey/white literature to include ECPAT, WeProtect Global Alliance, and other tech-focused organizations. -Data extraction should clearly document the type of violence addressed, type of data (if any) collected (personally identifiable information? violence outcomes? indirect outcomes? no outcomes at all?) -What do you mean by 'facilitators' to be extracted? -In the discussion, you talk about informing city/state governments. Since this is a global study, can 'national' governments also be added? Reviewer #3: Please accept my review of manuscript #PONE-D-25-09607, which is being considered for publication in PLOS ONE. This manuscript outlines an evidence-based protocol with which the authors plan to conduct a scoping review. The focus of this review will be technology’s impacts on either mitigating or facilitating sexual and interpersonal violence (SIV) amongst 8-25 year olds. The protocol has many strengths, including filling a needed gap in the literature on factors influencing technology-facilitated or -mitigated SIV, responding to a rising form of SIV with both a preventative and responsive intention, as well as the rigor and depth of the proposed scoping review. In addition to these strengths, I included suggestions for improvements below, which focus on increasing clarity of wording and purpose, flow, citations, and minor suggestions on methodology. Overall, I think this is an important study and a well-devised protocol that will be ready for publication with some revisions. Paper-wide suggestions: Please use consistent either APA or AMA-style in-text citation formatting. AMA would include superscript numbering, while APA would include the author last names and publication date in parentheses. General recommendation: please clarify more thoroughly, in both the introduction and method, why a scoping review is the best choice of review type for this study. Abstract: Please include the full version of the abbreviation PRISMA-P. Briefly mention that Covidence is a type of software for those who are unfamiliar. Introduction: I have an issue with the way SIV is presented in the first paragraph. Think about and revisit. Line 67: “age-groups” does not need a hyphen. Line 70: “(11,12).Sexual”: insert a space. Line 80: “Adolescents and young adults are easy target of “: change to targets. Line 81: “both in partner and non-partner contexts”: please change to “partnered and non-partnered” Line 82: the word “penetration” is inappropriately used in this sentence. Do you mean frequency or prevalence? Line 85: please say “in the United States” Line 85: “Youth aged 13-17 years were found to be at the highest risk of technology-assited abuse, with majority of the perpetrators being older than this age-group (18).” Perhaps a more precise and grammatically correct way to word this is something like: In fact, one study found that youth aged 13-17 were the age group with the highest risk of being victimized by technology-assisted abuse, with the majority of perpetrators being older than this age group (18). Line 94: “use(21,22)” insert a space after “use.” Lines 94-98: Please be more specific about the “topics” that adolescents may develop “incorrect” perceptions about; also, please be more specific about what is meant by “content-based data practices” and survivor-centered “design.” I also suggest citing all of these claims. Line 103: what is an example of a potential ethical issue that may have been reported in the past? Lines 113-120: please be sure to cite all claims. Method: General recommendation: please include a description of how the “needs of diverse populations” will be methodologically approached, such as whether it will be a specific research question or piece of extracted data, as this goal is mentioned in both the introduction and discussion. Line 135: add period. Research question 2: This is a great question, yet it might be more scientifically fruitful to answer if it is reworded as an open question. For example, “To what extent has technology been effective in facilitating…” may give you more room to answer this question qualitatively. The parenthetical portion of your 3rd research question is important background information about ethical considerations in SIV-related technology. I suggest integrating this information into a new paragraph in your introduction so that the reader is more aware of the possibilities regarding ethical and safety issues that are reasonable to suspect could be helpful or harmful. Line 156: please cite. Concept section: Similarly to my suggestion above, your description of prevention versus response strategies in this section is very helpful and would be important to address in your introduction more thoroughly to justify the focus on these types of studies. Lines 185-186: It would read better to reword the information inside the parentheses as a separate sentence. Lines 206-207. Please justify more fully why you will not “conduct a critical appraisal, assess methodological limitations, or evaluate the risk of bias due to the nature of study.” Every study would likely benefit from these practices, so please include more rationale for these choices. Furthermore, this statement is confusing as just after this (e.g., line 211), there is a statement regarding bias mitigation. Therefore, it would be best to either have a subsection describing such bias mitigation strategies, methodological limitations, etc., and/or more fully explain what is meant by the statement in lines 206-207. Line 212: you write that you will conduct a pilot and refinement stage, followed by the sentence, “The research team will test it on at least three studies to confirm its accuracy and completeness.” I believe that this sentence is your description of what your piloting stage will entail, but this is slightly unclear. Please connect that this is your piloting plan, if that is correct. Data Analysis section: please include a citation regarding your intended qualitative data analysis, and name your specific qualitative analytic approach (I believe you are describing thematic analysis). I also suggest expanding more on your plan to use reflexivity, including what the process will entail and why it is recommended and by whom. Line 232: please cite. Reviewer #4: I recommend for the authors to outline how they intend to share their findings from the study once it is completed. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Prof. Yordanis Enriquez Canto Reviewer #2: Yes: Ashleigh L Howard Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org
|
| Revision 1 |
|
Using Safe and Ethical Technology to Prevent and Respond to Sexual and Interpersonal Violence during Adolescence and Young Adulthood: Identifying Evidence, Best Practices, and Pathways Forward—A Global Scoping Review Protocol PONE-D-25-09607R1 Dear Dr. Shirzad, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Morteza Arab-Zozani, Ph. D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-09607R1 PLOS ONE Dear Dr. Shirzad, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Morteza Arab-Zozani Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .